Relative impact of fatigue and subclinical cognitive brain dysfunction on health-related quality of life in chronic hepatitis C infection

AIDS

Volumn 19, Issue SUPPL. 3, 2005, Pages

  Kramer, Ludwig ^a   Hofer, Harald ^a   Bauer, Edith ^a   Funk, Georg ^a   Formann, Elisabeth ^a   Steindl Munda, Petra ^a   Ferenci, Peter ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cognitive; Depression; Encephalopathy; Event related potentials; Fatigue; Hepatitis C; Quality of life; Score

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY BURDEN; BRAIN DYSFUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EVENT RELATED POTENTIAL; FATIGUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; HYPOTHESIS; LIVER CIRRHOSIS; LIVER FUNCTION; MALE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RATING SCALE; SCORING SYSTEM; SHORT FORM 36; VALIDATION PROCESS;

EID: 27944481695     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000192075.26314.87     Document Type: Article

References (42)

1. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340:1228-1233.
2. Goh J, Coughlan B, Quinn J, O'Keane JC, Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1999; 11:833-888.
3. Gershon AS, Margulies M, Gorczynski RM, Heathcote EJ. Serum cytokine values and fatigue in chronic hepatitis C infection. J Viral Hepat 2000; 7:397-402.
4. Jamal MM, Soni A, Quinn PG, Wheeler DE, Arora S, Johnston DE. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States. Hepatology 1999; 30:1307-1311.
5. Poynard T, Cacoub P, Ratziu V, Myers RP, Dezailles MH, Mercadier A, et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat 2002; 9:295-303.
6. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35:433-439.
7. Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, et al. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37:349-354.
8. Cordoba J, Flavia M, Jacas C, Sauleda S, Esteban JI, Vargas V, et al. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003; 39:231-238.
9. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: Initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18 (Suppl. 1):S79-S83.
10. Mendoza TR, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK, et al. The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 1999; 85:1186-1196.
11. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
12. Ware JE Jr. SF-36 health survey: manual and interpretation guide. Boston: New England Medical Center; 1993.
13. Brazier JE, Harper R, Jones NM, O'Cathain A, Thomas KJ, Usherwood T, et al. Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992; 305:160-164.
14. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994; 18 (Suppl. 1):S79-S83.
15. Häusser W, Almouhtasseb R, Muthny FA, Grandt D. Validation of the German version of the Fatigue Impact Scale FIS-D [in German]. Z Gastroenterol 2003; 41:973-982.
16. Radbruch L, Sabatowski R, Elsner F, Evertz J, Mendozy T, Cleeland C. Validation of the German version of the Brief Fatigue Inventory. J Pain Symptom Management 2003; 25:449-458.
17. Ludwig J. Histopathological diagnosis and terminology of chronic hepatitis. J Hepatol 1995; 23 (Suppl. 1):49-53.
18. Fletcher A, Gore S, Jones D, Fitzpatrick R, Spiegelhalter D, Cox D. Quality of life measures in health care. II. Design, analysis, and interpretation. BMJ 1992; 305:1145-1148.
19. Belsley DA, Kuh E, Welsch RE. Regression diagnostics: identifying influential data and sources of collinearity. New York: John Wiley and Sons; 1980.
20. Forton DM, Thomas HC, Taylor-Robinson SD. Quality of life and cognitive function in chronic hepatitis C - what to measure? J Hepatol 2003; 39:272-274.
21. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30:1299-1301.
22. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26 (Suppl. 1):15S-20S.
23. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340:1228-1233.
24. Cacoub P, Ratziu V, Myers RP, Ghiliani P, Piette JC, Moussalli J, et al. Impact of treatment on extra hepatic manifestation in patients with chronic hepatitis C. J Hepatol 2002; 36:812-818.
25. Jain SK, Pemberton PW, Smith A, McMahon RF, Burrows PC, Aboutwerat A, et al. Oxidative stress in chronic hepatitis C: not just a feature of late stage disease. J Hepatol 2002; 36:805-811.
26. Kozanoglu E, Canataroglu A, Abayli B, Colakoglu S, Goncu K. Fibromyalgia syndrome in patients with hepatitis C infection. Rheumatol Int 2003; 23:248-251.
27. Chao LL, Lindgren JA, Flenniken DL, Weiner MW. ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy. Clin Neurophysiol 2004; 115:1583-1591.
28. De Bona M, Ponton P, Ermani M, lemmolo RM, Feltrin A, Boccagni P, et al. The impact of liver disease and medical complications on quality of life and psychological distress before and after liver transplantation. J Hepatol 2000; 33:609-615.
29. Bonkovsky HL, Wooley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The consensus interferon study group. Hepatology 1999; 29:264-270.
30. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27:209-212.
31. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35:433-439.
32. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC. Identification of unique hepatitis C virus quasi-species in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004; 78:5170-5183.
33. Datz C, Cramp M, Haas T, Dietze O, Nitschko H, Froesner G, et al. The natural course of hepatitis C virus infection 18 years after an epidemic outbreak of non-A, non-B hepatitis in a plasmapheresis centre. Gut 1999; 44:563-567.
34. Fleming CA, Christiansen D, Nunes D, Heeren T, Thornton D, Horsburgh CR, et al. Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection. Clin Infect Dis 2004; 38:572-578.
35. DeFlorio M, Massie MJ. Review of depression in cancer: gender differences. Depression 1995; 3:66-80.
36. Soriano V, Sulkowski M, Bergin C, Hatzakis A, Cacoub P, Katlama C, et al. Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel. AIDS 2002; 16:813-823.
37. Hassanein T, Cooksley G, Sulkowski M, Smith C, Marinos G, Lai MY, et al. The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C. J Hepatol 2004; 40:675-681.
38. Becker PM, Schwartz JR, Feldman NT, Hughes RJ. Effect of modafinil on fatigue, mood, and health-related quality of life in patients with narcolepsy. Psychopharmacology (Berl) 2004; 171:133-139.
39. Turner J, Hayes S, Reul-Hirche H. Improving the physical status and quality of life of women treated for breast cancer: a pilot study of a structured exercise intervention. J Surg Oncol 2004; 86:141-146.
40. Smitha BA, Neidig JL, Nickele JT, Mitchell GL, Parab MF, Fassb RJ. Aerobic exercise: effects on parameters related to fatigue, dyspnea, weight and body composition in HIV-infected adults. AIDS 2001; 15:693-701.
41. McDonald J, Jayasuriya R, Bindley P, Gonsalvez C, Glusseka S. Fatigue and psychological disorders in chronic hepatitis C. J Gastroenterol Hepatol 2002; 17:171-176.
42. Cordoba J, Reyes J, Esteban JI. Labeling may be an important cause of reduced quality of life in chronic hepatitis C [Letter]. Am J Gastroenterol 2003; 68:226-227.